Influenza Pandemics

Chapter
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 719)

Abstract

The recent H1N1 pandemic that emerged in 2009 has illustrated how swiftly a new influenza virus can circulate the globe. Here we explain the origins of the 2009 pandemic virus, and other twentieth century pandemics. We also consider the impact of the 2009 pandemic in the human population and the use of vaccines and antiviral drugs. Thankfully this outbreak was much less severe than that associated with Spanish flu in 1918. We describe the viral factors that affect virulence of influenza and speculate on the future course of this virus in humans and animals.

Keywords

Obesity Recombination Pneumonia Influenza Bacillus 

References

  1. 1.
    Morens DM, Taubenberger JK, Harvey HA, Memoli MJ. The 1918 influenza pandemic: lessons for 2009 and the future. Critical Care Medicine. 2010;38(4 Suppl):e10–20.PubMedCrossRefGoogle Scholar
  2. 2.
    Johnson NPAS, Mueller J. Updating the accounts: global mortality of the 1918–1920 “Spanish” influenza pandemic. Bulletin of the History of Medicine. 2002 Jan;76(1):105–15PubMedCrossRefGoogle Scholar
  3. 3.
    Gouarin S, Vabret A, Dina J, Petitjean J, Brouard J, Freymuth F. Study of Influenza C Virus Infection in France. Ibis. 2008;1446(April):1441–1446.Google Scholar
  4. 4.
    Shope RE. Swine Influenza : I. Experimental Transmission and Pathology. The Journal of Experimental Medicine. 1931 Jul;54(3):349–59.PubMedCrossRefGoogle Scholar
  5. 5.
    Shope RE. The Etiology of Swine Influenza. Science (New York, N.Y.). 1931 Feb;73(1886):214–5.PubMedCrossRefGoogle Scholar
  6. 6.
    Laidlaw PP, Smith W, with C. H. The susceptibility of mice to the viruses of human and swine influenza. Lancet, The. 1934;2(859):Google Scholar
  7. 7.
    Andrewes CH, Laidlaw PP, with W. Virus obtained from influenza patients. Lancet, The. 1933;19(66):Google Scholar
  8. 8.
    Taubenberger JK, Morens DM. 1918 Influenza: the mother of all pandemics. Emerging Infectious Diseases. 2006 Jan;12(1):15–22.PubMedGoogle Scholar
  9. 9.
    Reid AH, Fanning TG, Hultin JV, Taubenberger JK. Origin and evolution of the 1918 “Spanish” influenza virus hemagglutinin gene. Proceedings of the National Academy of Sciences of the United States of America. 1999 Feb;96(4):1651–6.PubMedCrossRefGoogle Scholar
  10. 10.
    Taubenberger JK. Initial Genetic Characterization of the 1918 “Spanish” Influenza Virus Science. 1997 Mar;275(5307):1793–1796.PubMedCrossRefGoogle Scholar
  11. 11.
    Tumpey TM, Basler CF, Aguilar PV, Zeng H, Solórzano A, Swayne DE, et al. Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science (New York, N.Y.). 2005 Oct;310(5745):77–80.PubMedCrossRefGoogle Scholar
  12. 12.
    Reid AH, Fanning TG, Janczewski TA, Taubenberger JK. Characterization of the 1918 “Spanish” influenza virus neuraminidase gene. Proceedings of the National Academy of Sciences of the United States of America. 2000 Jun;97(12):6785–90.PubMedCrossRefGoogle Scholar
  13. 13.
    Basler CF, Reid AH, Dybing JK, Janczewski TA, Fanning TG, Zheng H, et al. Sequence of the 1918 pandemic influenza virus nonstructural gene (NS) segment and characterization of recombinant viruses bearing the 1918 NS genes. Proceedings of the National Academy of Sciences of the United States of America. 2001 Feb;98(5):2746–51.PubMedCrossRefGoogle Scholar
  14. 14.
    Reid AH, Fanning TG, Janczewski TA, McCall S, Taubenberger JK. Characterization of the 1918 “Spanish” influenza virus matrix gene segment. Journal of Virology. 2002 Nov;76(21):10717–23.PubMedCrossRefGoogle Scholar
  15. 15.
    Reid AH, Fanning TG, Janczewski TA, Lourens RM, Taubenberger JK. Novel origin of the 1918 pandemic influenza virus nucleoprotein gene. Journal of Virology. 2004 Nov;78(22):12462–70.PubMedCrossRefGoogle Scholar
  16. 16.
    Taubenberger JK, Reid AH, Lourens RM, Wang R, Jin G, Fanning TG. Characterization of the 1918 influenza virus polymerase genes. Nature. 2005 Oct;437(7060):889–93.PubMedCrossRefGoogle Scholar
  17. 17.
    Brand JMA van den, Stittelaar KJ, Amerongen G van, Rimmelzwaan GF, Simon J, Wit E de, et al. Severity of pneumonia due to new H1N1 influenza virus in ferrets is intermediate between that due to seasonal H1N1 virus and highly pathogenic avian influenza H5N1 virus. The Journal of Infectious Diseases. 2010 Apr;201(7):993–9.PubMedCrossRefGoogle Scholar
  18. 18.
    Memoli MJ, Tumpey TM, Jagger BW, Dugan VG, Sheng Z-M, Qi L, et al. An early “classical” swine H1N1 influenza virus shows similar pathogenicity to the 1918 pandemic virus in ferrets and mice. Virology. 2009;393(2):338–345.PubMedCrossRefGoogle Scholar
  19. 19.
    Tumpey TM, García-Sastre A, Taubenberger JK, Palese P, Swayne DE, Basler CF. Pathogenicity and immunogenicity of influenza viruses with genes from the 1918 pandemic virus. Proceedings of the National Academy of Sciences of the United States of America. 2004;101(9):3166–3171.PubMedCrossRefGoogle Scholar
  20. 20.
    Weingartl HM, Albrecht RA, Lager KM, Babiuk S, Marszal P, Neufeld J, et al. Experimental infection of pigs with the human 1918 pandemic influenza virus. Journal of Virology. 2009;83(9):4287–4296.PubMedCrossRefGoogle Scholar
  21. 21.
    Meunier I, Pillet S, Simonsen JN, Messling V von. Influenza pathogenesis: lessons learned from animal studies with H5N1, H1N1 Spanish, and pandemic H1N1 2009 influenza. Critical Care Medicine. 2010 Apr;38(4 Suppl):e21-9.PubMedCrossRefGoogle Scholar
  22. 22.
    Watanabe T, Watanabe S, Shinya K, Kim JH, Hatta M, Kawaoka Y. Viral RNA polymerase complex promotes optimal growth of 1918 virus in the lower respiratory tract of ferrets. Proceedings of the National Academy of Sciences of the United States of America. 2009 Jan;106(2):588–92.PubMedCrossRefGoogle Scholar
  23. 23.
    Belser J a, Wadford DA, Pappas C, Gustin KM, Maines TR, Pearce MB, et al. Pathogenesis of pandemic influenza A (H1N1) and triple-reassortant swine influenza A (H1) viruses in mice. Journal of Virology. 2010 May;84(9):4194–203.PubMedCrossRefGoogle Scholar
  24. 24.
    Klugman KP, Mills Astley C, Lipsitch M. Time from Illness Onset to Death, 1918 Infl uenza and Pneumococcal Pneumonia Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2009 Apr;15(2):346–347.PubMedCrossRefGoogle Scholar
  25. 25.
    Morens DM, Taubenberger JK, Fauci AS. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. The Journal of Infectious Diseases. 2008 Oct;198(7):962–70.PubMedCrossRefGoogle Scholar
  26. 26.
    Brown JN, Palermo RE, Baskin CR, Gritsenko M, Sabourin PJ, Long JP, et al. Macaque Proteome Response to Highly Pathogenic Avian Influenza and 1918 Reassortant Influenza Virus Infections. Journal of Virology. 2010 Sep;Google Scholar
  27. 27.
    Billharz R, Zeng H, Proll SC, Korth MJ, Lederer S, Albrecht R, et al. The NS1 protein of the 1918 pandemic influenza virus blocks host interferon and lipid metabolism pathways. Journal of Virology. 2009 Oct;83(20):10557–70.PubMedCrossRefGoogle Scholar
  28. 28.
    Kash JC, Basler CF, García-Sastre A, Carter V, Billharz R, Swayne DE, et al. Global host immune response: pathogenesis and transcriptional profiling of type A influenza viruses expressing the hemagglutinin and neuraminidase genes from the 1918 pandemic virus. Journal of Virology. 2004 Sep;78(17):9499–511.PubMedCrossRefGoogle Scholar
  29. 29.
    Kobasa D, Jones SM, Shinya K, Kash JC, Copps J, Ebihara H, et al. Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature. 2007 Jan;445(7125):319–23.PubMedCrossRefGoogle Scholar
  30. 30.
    Nelson MI, Viboud C, Simonsen L, Bennett RT, Griesemer SB, St George K, et al. Multiple reassortment events in the evolutionary history of H1N1 influenza A virus since 1918. PLoS Pathogens. 2008 Feb;4(2):e1000012.PubMedCrossRefGoogle Scholar
  31. 31.
    Lagacé-Wiens PRS, Rubinstein E, Gumel A. Influenza epidemiology–past, present, and future. Critical Care Medicine. 2010 Apr;38(4 Suppl):e1-9.PubMedCrossRefGoogle Scholar
  32. 32.
    Cox NJ, Subbarao K. Global epidemiology of influenza: past and present. Annual Review of Medicine. 2000 Jan;51407–21.PubMedCrossRefGoogle Scholar
  33. 33.
    Wertheim JO. The re-emergence of H1N1 influenza virus in 1977: a cautionary tale for estimating divergence times using biologically unrealistic sampling dates. PloS One. 2010 Jan;5(6):e11184.PubMedCrossRefGoogle Scholar
  34. 34.
    Zimmer SM, Burke DS. Historical perspective–Emergence of influenza A (H1N1) viruses. The New England Journal of Medicine. 2009 Jul;361(3):279–85.PubMedCrossRefGoogle Scholar
  35. 35.
    Scholtissek C, Hoyningen V von, Rott R. Genetic relatedness between the new 1977 epidemic strains (H1N1) of influenza and human influenza strains isolated between 1947 and 1957 (H1N1). Virology. 1978 Sep;89(2):613–7.PubMedCrossRefGoogle Scholar
  36. 36.
    Nakajima K, Desselberger U, Palese P. Recent human influenza A (H1N1) viruses are closely related genetically to strains isolated in 1950. Nature. 1978 Jul;274(5669):334–9.PubMedCrossRefGoogle Scholar
  37. 37.
    Kishida N, Sakoda Y, Isoda N, Matsuda K, Eto M, Sunaga Y, et al. Pathogenicity of H5 influenza viruses for ducks. Archives of Virology. 2005 Jul;150(7):1383–92.PubMedCrossRefGoogle Scholar
  38. 38.
    Homme PJ, Easterday BC. Avian influenza virus infections. IV. Response of pheasants, ducks, and geese to influenza A-turkey-Wisconsin-1966 virus. Avian Diseases. 1970 May;14(2):285–90.PubMedCrossRefGoogle Scholar
  39. 39.
    Krauss S, Webster R. Avian Influenza Virus Surveillance and Wild Birds: Past and Present. Avian Diseases. 2010;(54):394–398.PubMedCrossRefGoogle Scholar
  40. 40.
    Stallknecht DE, Kearney MT, Shane SM, Zwank PJ. Effects of pH, temperature, and salinity on persistence of avian influenza viruses in water. Avian Diseases. 1990;34(2):412–8.PubMedCrossRefGoogle Scholar
  41. 41.
    Stallknecht DE, Shane SM, Kearney MT, Zwank PJ. Persistence of avian influenza viruses in water. Avian Diseases. 1990;34(2):406–11.PubMedCrossRefGoogle Scholar
  42. 42.
    Donis RO, Bean WJ, Kawaoka Y, Webster RG. Distinct lineages of influenza virus H4 hemagglutinin genes in different regions of the world. Virology. 1989 Apr;169(2):408–17.PubMedCrossRefGoogle Scholar
  43. 43.
    Thompson CI, Barclay WS, Zambon MC, Pickles RJ. Infection of human airway epithelium by human and avian strains of influenza a virus. Journal of Virology. 2006 Aug;80(16):8060–8.PubMedCrossRefGoogle Scholar
  44. 44.
    Thompson CI, Barclay WS, Zambon MC. Changes in in vitro susceptibility of influenza A H3N2 viruses to a neuraminidase inhibitor drug during evolution in the human host. The Journal of Antimicrobial Chemotherapy. 2004 May;53(5):759–65.PubMedCrossRefGoogle Scholar
  45. 45.
    WHO. WHO | Cumulative Number of Confirmed Human Cases of Avian Influenza A/(H5N1) Reported to WHO 2010.Google Scholar
  46. 46.
    Elliot AJ, et al. Surveillance of influenza-like illness in England and Wales during 1966–2006. Euro Surveill. 2006;11(10):pii=651. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=651.PubMedCrossRefGoogle Scholar
  47. 47.
    Lessler J, Cummings DAT, Fishman S, Vora A, Burke DS. Transmissibility of swine flu at Fort Dix, 1976. Journal of the Royal Society, Interface/The Royal Society. 2007 Aug;4(15):755–62.PubMedCrossRefGoogle Scholar
  48. 48.
    Gaydos JC, Top FH, Hodder RA, Russell PK. Swine Influenza A Outbreak, Fort Dix, New Jersey, 1976. Emerging Infectious Diseases. 2006;12(1):23–28.PubMedGoogle Scholar
  49. 49.
    Kida H, Ito T, Yasuda J, Shimizu Y, Itakura C, Shortridge KF, et al. Potential for transmission of avian influenza viruses to pigs. Journal of General Virology. 1994 Sep;75(9):2183–2188.PubMedCrossRefGoogle Scholar
  50. 50.
    Garten RJ, Davis CT, Russell C a, Shu B, Lindstrom S, Balish A, et al. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science (New York, N.Y.). 2009 Jul;325(5937):197–201.PubMedCrossRefGoogle Scholar
  51. 51.
    Smith GJD, Vijaykrishna D, Bahl J, Lycett SJ, Worobey M, Pybus OG, et al. Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature. 2009 Jun;459(7250):1122–5.PubMedCrossRefGoogle Scholar
  52. 52.
    Ito T, Couceiro JNSS, Kelm S, Baum LG, Krauss S, Castrucci MR, et al. Molecular Basis for the Generation in Pigs of Influenza A Viruses with Pandemic Potential J. Virol. 1998;72(9):7367–7373.PubMedGoogle Scholar
  53. 53.
    Naeve CW, Hinshaw VS, Webster RG. Mutations in the hemagglutinin receptor-binding site can change the biological properties of an influenza virus. Journal of Virology. 1984 Aug;51(2):567–9.PubMedGoogle Scholar
  54. 54.
    Matrosovich M, Tuzikov A, Bovin N, Gambaryan A, Klimov A, Castrucci MR, et al. Early alterations of the receptor-binding properties of H1, H2, and H3 avian influenza virus hemagglutinins after their introduction into mammals. Journal of Virology. 2000 Sep;74(18):8502–12.PubMedCrossRefGoogle Scholar
  55. 55.
    Pappas C, Viswanathan K, Chandrasekaran A, Raman R, Katz JM, Sasisekharan R, et al. Receptor Specificity and Transmission of H2N2 Subtype Viruses Isolated from the Pandemic of 1957. PloS One. 2010 Jan;5(6):e11158.PubMedCrossRefGoogle Scholar
  56. 56.
    Ayora-Talavera G, Shelton H, Scull M a, Ren J, Jones IM, Pickles RJ, et al. Mutations in H5N1 influenza virus hemagglutinin that confer binding to human tracheal airway epithelium. PloS One. 2009 Jan;4(11):e7836.PubMedCrossRefGoogle Scholar
  57. 57.
    Chutinimitkul S, Riel D van, Munster VJ, Brand JMA van den, Rimmelzwaan GF, Kuiken T, et al. In vitro assessment of attachment pattern and replication efficiency of H5N1 influenza A viruses with altered receptor specificity. Journal of Virology. 2010 Jul;84(13):6825–33.PubMedCrossRefGoogle Scholar
  58. 58.
    Nicholls JM, Chan RWY, Russell RJ, Air GM, Peiris JSM. Evolving complexities of influenza virus and its receptors. Trends in Microbiology. 2008 Apr;16(4):149–57.PubMedCrossRefGoogle Scholar
  59. 59.
    Stevens J, Blixt O, Glaser L, Taubenberger JK, Palese P, Paulson JC, et al. Glycan microarray analysis of the hemagglutinins from modern and pandemic influenza viruses reveals different receptor specificities. Journal of Molecular Biology. 2006 Feb;355(5):1143–55.PubMedCrossRefGoogle Scholar
  60. 60.
    Stevens J, Blixt O, Chen L-M, Donis RO, Paulson JC, Wilson I a. Recent avian H5N1 viruses exhibit increased propensity for acquiring human receptor specificity. Journal of Molecular Biology. 2008 Sep;381(5):1382–94.CrossRefGoogle Scholar
  61. 61.
    Blixt O, Head S, Mondala T, Scanlan C, Huflejt ME, Alvarez R, et al. Printed covalent glycan array for ligand profiling of diverse glycan binding proteins. Proceedings of the National Academy of Sciences of the United States of America. 2004 Dec;101(49):17033–8.PubMedCrossRefGoogle Scholar
  62. 62.
    Liao H-Y, Hsu C-H, Wang S-C, Liang C-H, Yen H-Y, Su C-Y, et al. Differential Receptor Binding Affinities of Influenza Hemagglutinins on Glycan Arrays. Journal of the American Chemical Society. 2010 Sep;286–291.Google Scholar
  63. 63.
    Childs RA, Palma AS, Wharton S, Matrosovich T, Liu Y, Chai W, et al. Receptor-binding specificity of pandemic influenza A (H1N1) 2009 virus determined by carbohydrate microarray. Nature Biotechnology. 2010 Feb;28(2):178–178.CrossRefGoogle Scholar
  64. 64.
    Trifonov V, Khiabanian H, Rabadan R. Influenza A (H1N1) Virus. Emerging Infectious Diseases. 2009;115–119.Google Scholar
  65. 65.
    Pebody RG, McLean E, Zhao H, Cleary P, Bracebridge S, Foster K, et al. Pandemic Influenza A (H1N1) 2009 and mortality in the United Kingdom: risk factors for death, April 2009 to March 2010. Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles  =  European Communicable Disease Bulletin. 2010 Jan;15(20):1–11.Google Scholar
  66. 66.
    HPA. The role of the Health Protection Agency in the “containment” phase during the first wave of pandemic influenza in England in 2009. 2010.Google Scholar
  67. 67.
    Miller E, Hoschler K, Hardelid P, Stanford E, Andrews N, Zambon M. Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study. The Lancet. 2010 Apr;375(9720):1100–1108.CrossRefGoogle Scholar
  68. 68.
    HPA. Weekly epidemiological update 2010;36[cited 2010 Sep 13] Available from: http://www.hpa.org.uk/web/HPAweb&Page&HPAwebAutoListName/Page/1243928258560.
  69. 69.
    WHO. WHO | Pandemic (H1N1) 2009 - update 112 World Health Organisation, Global Alert Response. 2010;Google Scholar
  70. 70.
    Girard MP, Katz J, Pervikov Y, Palkonyay L, Kieny M-P. Report of the 6th meeting on the evaluation of pandemic influenza vaccines in clinical trials World Health Organization, Geneva, Switzerland, 17–18 February 2010. Vaccine. 2010 Oct;28(42):6811–20.Google Scholar
  71. 71.
    Johnson BF, Wilson LE, Ellis J, Elliot AJ, Barclay WS, Pebody RG, et al. Fatal cases of influenza a in childhood. PloS One. 2009 Jan;4(10):e7671.PubMedCrossRefGoogle Scholar
  72. 72.
    Sachedina N, Donaldson LJ. Paediatric mortality related to pandemic influenza A H1N1 infection in England: an observational population-based study. The Lancet. 2010 Oct;6736(10):1–7.Google Scholar
  73. 73.
    Rothberg MB, Haessler SD. Complications of seasonal and pandemic influenza. Critical Care Medicine. 2010;38(4 Suppl):e91-7.PubMedCrossRefGoogle Scholar
  74. 74.
    Ferguson NM, Cummings DAT, Fraser C, Cajka JC, Cooley PC, Burke DS. Strategies for mitigating an influenza pandemic. Nature. 2006;442(7101):448–452.PubMedCrossRefGoogle Scholar
  75. 75.
    Kawaguchi R. Influenza (H1N1) 2009 Outbreak and School Closure, Osaka Prefecture, Japan. Emerging Infectious Diseases. 2009 Oct;15(10):2009-2009.Google Scholar
  76. 76.
    Wu JT. School Closure and Mitigation of Pandemic (H1N1) 2009, Hong Kong. Emerging Infectious Diseases. 2010 Mar;16(3):10–13.Google Scholar
  77. 77.
    Miller E, Hoschler K, Hardelid P, Stanford E, Andrews N, Zambon M. Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study. The Lancet. 2010;375(9720):1100–1108.CrossRefGoogle Scholar
  78. 78.
    Wu JT, Ma ESK, Lee CK, Chu DKW, Ho P, Shen AL, et al. The Infection Attack Rate and Severity of 2009 Pandemic H1N1 Influenza in Hong Kong. Clinical Infectious Diseases. 2010 Nov;51(10):1184–1191PubMedCrossRefGoogle Scholar
  79. 79.
    Reyes L, Arvelo W, Estevez A, Gray J, Moir JC, Gordillo B, et al. Population-based surveillance for 2009 pandemic influenza A (H1N1) virus in Guatemala, 2009. Influenza and Other Respiratory Viruses. 2010 May;4(3):129–40.PubMedCrossRefGoogle Scholar
  80. 80.
    Libster R, Bugna J, Coviello S, Hijano DR, Dunaiewsky M, Reynoso N, et al. Pediatric hospitalizations associated with 2009 pandemic influenza A (H1N1) in Argentina. The New England Journal of Medicine. 2010;362(1):45–55.PubMedCrossRefGoogle Scholar
  81. 81.
    ’t Klooster T van, Wielders C, Donker T, Isken L, Meijer A, Den Wijngaard C van, et al. Surveillance of Hospitalisations for 2009 Pandemic Influenza A(H1N1) in the Netherlands, 5 June – 31 December 2009 Eurosurveillance. 2010;15(2):4.Google Scholar
  82. 82.
    Pitman RJ, Melegaro A, Gelb D, Siddiqui MR, Gay NJ, Edmunds WJ. Assessing the burden of influenza and other respiratory infections in England and Wales. The Journal of Infection. 2007 Jun;54(6):530–8.PubMedCrossRefGoogle Scholar
  83. 83.
    Zhao C, Gan Y, Sun J. Radiographic study of severe Influenza-A (H1N1) disease in children. European Journal of Radiology. 2010 Oct;1–5.Google Scholar
  84. 84.
    Zheng Y, He Y, Deng J, Lu Z, Wei J, Yang W, et al. Hospitalized children with 2009 influenza a (H1N1) infection in Shenzhen, China, november-december 2009. Pediatric Pulmonology. 2010 Oct;(July):1–7.Google Scholar
  85. 85.
    Halasa NB. Update on the 2009 pandemic influenza A H1N1 in children. Current Opinion in Pediatrics. 2010 Feb;22(1):83–7.PubMedCrossRefGoogle Scholar
  86. 86.
    Feiterna-Sperling C, Edelmann A, Nickel R, Magdorf K, Bergmann F, Rautenberg P, et al. Pandemic Influenza A (H1N1) Outbreak among 15 School-Aged HIV-1-Infected Children. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America. 2010 Nov;518–12.Google Scholar
  87. 87.
    Falagas ME, Koletsi PK, Baskouta E, Rafailidis PI, Dimopoulos G, Karageorgopoulos DE. Pandemic A(H1N1) 2009 influenza: review of the Southern Hemisphere experience. Epidemiology and Infection. 2010 Oct;5:1–14.Google Scholar
  88. 88.
    Sasbón JS, Centeno M a, García MD, Boada NB, Lattini BE, Motto E a, et al. Influenza A (pH1N1) infection in children admitted to a pediatric intensive care unit: Differences with other respiratory viruses. Pediatric Critical Care Medicine: A Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies. 2010 Apr;12(1):1–5.Google Scholar
  89. 89.
    Bautista E, Chotpitayasunondh T, Gao Z, Harper S a, Shaw M, Uyeki TM, et al. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. The New England Journal of Medicine. 2010 May;362(18):1708–19.PubMedCrossRefGoogle Scholar
  90. 90.
    Siston AM, Rasmussen S a, Honein M a, Fry AM, Seib K, Callaghan WM, et al. Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States. JAMA : The Journal of the American Medical Association. 2010 Apr;303(15):1517–25.CrossRefGoogle Scholar
  91. 91.
    Goodnight WH, Soper DE. Pneumonia in pregnancy. Critical Care Medicine. 2005 Oct;33(Supplement):S390-S397.PubMedCrossRefGoogle Scholar
  92. 92.
    Rasmussen S a, Jamieson DJ, Bresee JS. Pandemic influenza and pregnant women. Emerging Infectious ­Diseases. 2008 Jan;14(1):95–100.PubMedCrossRefGoogle Scholar
  93. 93.
    Jamieson DJ, Theiler RN, Rasmussen S a. Emerging infections and pregnancy. Emerging Infectious Diseases. 2006 Nov;12(11):1638–43.PubMedCrossRefGoogle Scholar
  94. 94.
    Gordon CL, Johnson PDR, Permezel M, Holmes NE, Gutteridge G, McDonald CF, et al. Association between severe pandemic 2009 influenza A (H1N1) virus infection and immunoglobulin G(2) subclass deficiency. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America. 2010 Mar;50(5):672–8.Google Scholar
  95. 95.
    Nguyen-Van-Tam JS, Openshaw PJM, Hashim a, Gadd EM, Lim WS, Semple MG, et al. Risk factors for hospitalisation and poor outcome with pandemic A/H1N1 influenza: United Kingdom first wave (May-September 2009). Thorax. 2010 Jul;65(7):645–51.PubMedCrossRefGoogle Scholar
  96. 96.
    Shieh W-J, Blau DM, Denison AM, Deleon-Carnes M, Adem P, Bhatnagar J, et al. 2009 pandemic influenza A (H1N1): pathology and pathogenesis of 100 fatal cases in the United States. The American Journal of Pathology. 2010 Jul;177(1):166–75.PubMedCrossRefGoogle Scholar
  97. 97.
    Gill JR, Sheng Z-M, Ely SF, Guinee DG, Beasley MB, Suh J, et al. Pulmonary pathologic findings of fatal 2009 pandemic influenza A/H1N1 viral infections. Archives of Pathology & Laboratory Medicine. 2010 Feb;134(2):235–43.Google Scholar
  98. 98.
    Mauad T, Hajjar LA, Callegari GD, Silva LFF da, Schout D, Galas FRBG, et al. Lung pathology in fatal novel human influenza A (H1N1) infection. American Journal of Respiratory and Critical Care Medicine. 2010 Jan;181(1):72–9.PubMedCrossRefGoogle Scholar
  99. 99.
    Palacios G, Hornig M, Cisterna D, Savji N, Bussetti AV, Kapoor V, et al. Streptococcus pneumoniae coinfection is correlated with the severity of H1N1 pandemic influenza. PloS One. 2009 Jan;4(12):e8540.PubMedCrossRefGoogle Scholar
  100. 100.
    Waddington CS, Walker WT, Oeser C, Reiner A, John T, Wilkins S, et al. Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study. BMJ (Clinical research ed.). 2010 Jan;340c2649.Google Scholar
  101. 101.
    Munster VJ, Wit E de, Brand JM a van den, Herfst S, Schrauwen EJ a, Bestebroer TM, et al. Pathogenesis and transmission of swine-origin 2009 A(H1N1) influenza virus in ferrets. Science (New York, N.Y.). 2009 Jul;325(5939):481–3.PubMedGoogle Scholar
  102. 102.
    Itoh Y, Shinya K, Kiso M, Watanabe T, Sakoda Y, Hatta M, et al. In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature. 2009;460(7258):1021–1025.PubMedGoogle Scholar
  103. 103.
    Shinya K, Ebina M, Yamada S, Ono M, Kasai N, Kawaoka Y. Avian flu: influenza virus receptors in the human airway. Nature. 2006 Mar;440(7083):435–6.PubMedCrossRefGoogle Scholar
  104. 104.
    Bright RA, Medina M-jo, Xu X, Perez-Oronoz G, Wallis TR, Davis XM, et al. Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern. The Lancet. 2005 Oct;366(9492):1175–1181.CrossRefGoogle Scholar
  105. 105.
    Sweet C, Hayden FG, Jakeman KJ, Grambas S, Hay a J. Virulence of rimantadine-resistant human influenza A (H3N2) viruses in ferrets. The Journal of Infectious Diseases. 1991 Nov;164(5):969–72.PubMedCrossRefGoogle Scholar
  106. 106.
    Nelson MI, Simonsen L, Viboud C, Miller M a, Holmes EC. The origin and global emergence of adamantane resistant A/H3N2 influenza viruses. Virology. 2009 Jun;388(2):270–8.PubMedCrossRefGoogle Scholar
  107. 107.
    Rungrotmongkol T, Intharathep P, Malaisree M, Nunthaboot N, Kaiyawet N, Sompornpisut P, et al. Susceptibility of antiviral drugs against 2009 influenza A (H1N1) virus. Biochemical and Biophysical Research Communications. 2009 Jul;385(3):390–4.PubMedCrossRefGoogle Scholar
  108. 108.
    Moss RB, Davey RT, Steigbigel RT, Fang F. Targeting pandemic influenza: a primer on influenza antivirals and drug resistance. The Journal of Antimicrobial Chemotherapy. 2010 Jun;65(6):1086–93.PubMedCrossRefGoogle Scholar
  109. 109.
    Jefferson T, Jones M, Doshi P, Del Mar C. Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis BMJ. 2009 Dec;339(dec07 2):b5106-b5106.PubMedCrossRefGoogle Scholar
  110. 110.
    Carr J, Ives J, Kelly L, Lambkin R, Oxford J, Mendel D, et al. Influenza virus carrying neuraminidase with reduced sensitivity to oseltamivir carboxylate has altered properties in vitro and is compromised for infectivity and replicative ability in vivo. Antiviral Research. 2002 May;54(2):79–88.PubMedCrossRefGoogle Scholar
  111. 111.
    Ives J a L, Carr J a, Mendel DB, Tai CY, Lambkin R, Kelly L, et al. The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo. Antiviral Research. 2002 Aug;55(2):307–17.PubMedCrossRefGoogle Scholar
  112. 112.
    Meijer A. Oseltamivir-Resistant Influenza Virus A (H1N1), Europe, 2007–08 Season. Emerging Infectious Diseases. 2009 Apr;15(4):552–560.PubMedCrossRefGoogle Scholar
  113. 113.
    Collins PJ, Haire LF, Lin YP, Liu J, Russell RJ, Walker P a, et al. Structural basis for oseltamivir resistance of influenza viruses. Vaccine. 2009 Oct;27(45):6317–23.PubMedCrossRefGoogle Scholar
  114. 114.
    Rameix-Welti M-A, Enouf V, Cuvelier F, Jeannin P, Werf S van der. Enzymatic properties of the neuraminidase of seasonal H1N1 influenza viruses provide insights for the emergence of natural resistance to oseltamivir. PLoS Pathogens. 2008 Jul;4(7):e1000103.PubMedCrossRefGoogle Scholar
  115. 115.
    Chen H. Oseltamivir-Resistant Influenza A Pandemic (H1N1) 2009 Virus, Hong Kong, China Emerging Infectious Diseases. 2009 Dec;15(12):1970–1972.Google Scholar
  116. 116.
    Baz M, Abed Y, Papenburg J, Bouhy X, Hamelin M-E, Boivin G. Emergence of oseltamivir-resistant pandemic H1N1 virus during prophylaxis. The New England Journal of Medicine. 2009 Dec;361(23):2296–7.PubMedCrossRefGoogle Scholar
  117. 117.
    Duan S, Boltz DA, Seiler P, Li J, Bragstad K, Nielsen LP, et al. Oseltamivir-resistant pandemic H1N1/2009 influenza virus possesses lower transmissibility and fitness in ferrets. PLoS Pathogens. 2010 Jan;6(7):e1001022.PubMedCrossRefGoogle Scholar
  118. 118.
    Seibert CW, Kaminski M, Philipp J, Rubbenstroth D, Albrecht RA, Schwalm F, et al. Oseltamivir-resistant variants of the 2009 pandemic H1N1 influenza A virus are not attenuated in the guinea pig and ferret transmission models. Journal of Virology. 2010 Aug;Google Scholar
  119. 119.
    Hamelin M-È, Baz M, Abed Y, Couture C, Joubert P, Beaulieu É, et al. Oseltamivir-Resistant Pandemic A/H1N1 Virus Is as Virulent as Its Wild-Type Counterpart in Mice and Ferrets. PLoS Pathogens. 2010 Jul;6(7):e1001015.PubMedCrossRefGoogle Scholar
  120. 120.
    Miller RR, MacLean a R, Gunson RN, Carman WF. Occurrence of haemagglutinin mutation D222G in pandemic influenza A(H1N1) infected patients in the West of Scotland, United Kingdom, 2009–10. Euro Surveillance: Bulletin Européen Sur Les Maladies Transmissibles  =  European Communicable Disease Bulletin. 2010 Jan;15(16):19534–19534.Google Scholar
  121. 121.
    Puzelli S. Transmission of Hemagglutinin D222G Mutant Strain of Pandemic (H1N1) 2009 Virus. Emerging Infectious Diseases. 2010 May;16(5):2009–2011.Google Scholar
  122. 122.
    Melidou A, Gioula G, Exindari M, Chatzidimitriou D, Diza E, Malisiovas N. Molecular and phylogenetic analysis of the haemagglutinin gene of pandemic influenza H1N1 2009 viruses associated with severe and fatal infections. Virus Research. 2010 Aug;151(2):192–9.PubMedCrossRefGoogle Scholar
  123. 123.
    Chen H, Wen X, To KKW, Wang P, Tse H, Chan JFW, et al. Quasispecies of the D225G substitution in the hemagglutinin of pandemic influenza A(H1N1) 2009 virus from patients with severe disease in Hong Kong, China. The Journal of Infectious Diseases. 2010 May;201(10):1517–21.PubMedCrossRefGoogle Scholar
  124. 124.
    Liu Y, Childs RA, Matrosovich T, Wharton S, Palma AS, Chai W, et al. Altered receptor specificity and cell tropism of D222G haemagglutinin mutants from fatal cases of pandemic A(H1N1) 2009 influenza. Journal of Virology. 2010 SepGoogle Scholar
  125. 125.
    Antón A, Marcos MA, Martínez MJ, Ramón S, Martínez A, Cardeñosa N, et al. D225G mutation in the hemagglutinin protein found in 3 severe cases of 2009 pandemic influenza A (H1N1) in Spain. Diagnostic Microbiology and Infectious Disease. 2010 Jun;67(2):207–8.PubMedCrossRefGoogle Scholar
  126. 126.
    WHO. Preliminary review of D222G amino acid substitution in the haemagglutinin of pandemic influenza A (H1N1) 2009 viruses. Relevé épidémiologique hebdomadaire/Section d’hygiène du Secrétariat de la Société des Nations  =  Weekly epidemiological record/Health Section of the Secretariat of the League of Nations. 2010 Jan;85(4):21–2.Google Scholar
  127. 127.
    Chutinimitkul S, Herfst S, Steel J, Lowen AC, Ye J, Riel D van, et al. Virulence-associated substitution D222G in hemagglutinin of 2009 pandemic influenza A(H1N1) virus affects receptor binding. Journal of Virology. 2010 SepGoogle Scholar
  128. 128.
    Ning Z-Y, Luo M-Y, Qi W-B, Yu B, Jiao P-R, Liao M. Detection of expression of influenza virus receptors in tissues of BALB/c mice by histochemistry. Veterinary Research Communications. 2009 Aug;895–903.PubMedCrossRefGoogle Scholar
  129. 129.
    Chen W, Calvo PA, Malide D, Gibbs J, Schubert U, Bacik I, et al. A novel influenza A virus mitochondrial protein that induces cell death. Nature Medicine. 2001;7(12):1306–1312.PubMedCrossRefGoogle Scholar
  130. 130.
    Zamarin D, García-Sastre A, Xiao X, Wang R, Palese P. Influenza virus PB1-F2 protein induces cell death through mitochondrial ANT3 and VDAC1. PLoS Pathogens. 2005 Sep;1(1):e4.PubMedCrossRefGoogle Scholar
  131. 131.
    Zamarin D, Ortigoza MB, Palese P. Influenza A virus PB1-F2 protein contributes to viral pathogenesis in mice. Journal of Virology. 2006 Aug;80(16):7976–83.PubMedCrossRefGoogle Scholar
  132. 132.
    Gibbs JS, Malide D, Hornung F, Bennink JR, Yewdell JW. The Influenza A Virus PB1-F2 Protein Targets the Inner Mitochondrial Membrane via a Predicted Basic Amphipathic Helix That Disrupts Mitochondrial Function. Journal of Virology. 2003 Jul;77(13):7214–7224.PubMedCrossRefGoogle Scholar
  133. 133.
    McAuley JL, Hornung F, Boyd KL, Smith AM, McKeon R, Bennink J, et al. Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia. Cell Host & Microbe. 2007 Oct;2(4):240–9.CrossRefGoogle Scholar
  134. 134.
    McAuley JL, Zhang K, McCullers JA. The effects of influenza A virus PB1-F2 protein on polymerase activity are strain specific and do not impact pathogenesis. Journal of Virology. 2010 Jan;84(1):558–64.PubMedCrossRefGoogle Scholar
  135. 135.
    Mazur I, Anhlan D, Mitzner D, Wixler L, Schubert U, Ludwig S. The proapoptotic influenza A virus protein PB1-F2 regulates viral polymerase activity by interaction with the PB1 protein. Cellular Microbiology. 2008 May;10(5):1140–52.PubMedCrossRefGoogle Scholar
  136. 136.
    Zell R, Krumbholz A, Eitner A, Krieg R, Halbhuber K-J, Wutzler P. Prevalence of PB1-F2 of influenza A viruses. The Journal of General Virology. 2007 Feb;88(Pt 2):536–46.PubMedCrossRefGoogle Scholar
  137. 137.
    Henkel M, Mitzner D, Henklein P, Meyer-Almes F-J, Moroni A, Difrancesco ML, et al. The Proapoptotic Influenza A Virus Protein PB1-F2 Forms a Nonselective Ion Channel. PloS One. 2010 Jan;5(6):e11112.PubMedCrossRefGoogle Scholar
  138. 138.
    McCullers JA, English BK. Improving therapeutic strategies for secondary bacterial pneumonia following influenza. Future Microbiology. 2008 Aug;3397–404.PubMedCrossRefGoogle Scholar
  139. 139.
    Conenello GM, Zamarin D, Perrone LA, Tumpey T, Palese P. A single mutation in the PB1-F2 of H5N1 (HK/97) and 1918 influenza A viruses contributes to increased virulence. PLoS Pathogens. 2007 Oct;3(10):1414–21.PubMedCrossRefGoogle Scholar
  140. 140.
    Hai R, Schmolke M, Varga ZT, Manicassamy B, Wang TT, Belser JA, et al. PB1-F2 expression by the 2009 pandemic H1N1 influenza virus has minimal impact on virulence in animal models. Journal of Virology. 2010 May;84(9):4442–50.PubMedCrossRefGoogle Scholar
  141. 141.
    Hale BG, Randall RE, Ortín J, Jackson D. The multifunctional NS1 protein of influenza A viruses. The Journal of General Virology. 2008 Oct;89(Pt 10):2359–76.PubMedCrossRefGoogle Scholar
  142. 142.
    Steidle S, Martínez-Sobrido L, Mordstein M, Lienenklaus S, García-Sastre A, Stäheli P, et al. Glycine 184 in the non-structural protein NS1 determines virulence of influenza A virus strain PR8 without affecting the host interferon response. Journal of Virology. 2010 OctGoogle Scholar
  143. 143.
    Hale BG, Steel J, Medina RA, Manicassamy B, Ye J, Hickman D, et al. Inefficient control of host gene expression by the 2009 pandemic H1N1 influenza A virus NS1 protein. Journal of Virology. 2010 Jul;84(14):6909–22.PubMedCrossRefGoogle Scholar
  144. 144.
    Osterlund P, Pirhonen J, Ikonen N, Rönkkö E, Strengell M, Mäkelä SM, et al. Pandemic H1N1 2009 influenza A virus induces weak cytokine responses in human macrophages and dendritic cells and is highly sensitive to the antiviral actions of interferons. Journal of Virology. 2010 Feb;84(3):1414–22.PubMedCrossRefGoogle Scholar
  145. 145.
    Texas State Health services. Texas Influenza survelliance Report 2010–2011 Season MMWR Week 42 Texas Influenza survelliance Report 2010–2011 Season MMWR Week 42. 2010Google Scholar
  146. 146.
    Russell C a, Jones TC, Barr IG, Cox NJ, Garten RJ, Gregory V, et al. The global circulation of seasonal influenza A (H3N2) viruses. Science (New York, N.Y.). 2008 Apr;320(5874):340–6.PubMedCrossRefGoogle Scholar
  147. 147.
    Hensley SE, Das SR, Bailey AL, Schmidt LM, Hickman HD, Jayaraman A, et al. Hemagglutinin receptor binding avidity drives influenza A virus antigenic drift. Science (New York, N.Y.). 2009 Oct;326(5953):734–6.PubMedCrossRefGoogle Scholar
  148. 148.
    Thompson CI, Barclay WS, Zambon MC. Changes in in vitro susceptibility of influenza A H3N2 viruses to a neuraminidase inhibitor drug during evolution in the human host. The Journal of Antimicrobial Chemotherapy. 2004 May;53(5):759–65.PubMedCrossRefGoogle Scholar
  149. 149.
    Vijaykrishna D, Poon LLM, Zhu HC, Ma SK, Li OTW, Cheung CL, et al. Reassortment of pandemic H1N1/2009 influenza A virus in swine. Science (New York, N.Y.). 2010 Jun;328(5985):1529.PubMedCrossRefGoogle Scholar
  150. 150.
    Kido H, Yokogoshi Y, Sakai K, Tashiro M, Kishino Y, Fukutomi a, et al. Isolation and characterization of a novel trypsin-like protease found in rat bronchiolar epithelial Clara cells. A possible activator of the viral fusion glycoprotein. The Journal of Biological Chemistry. 1992 Jul 5;267(19):13573–9.PubMedCrossRefGoogle Scholar
  151. 151.
    Stieneke-Grober A, Vey M, Angliker H, et al. Influenza virus hemagglutinin with multibasic cleavage site is activated by furin, a subtilisin-like endoprotease. EMBO J 1992;11:2407–2414.PubMedCrossRefGoogle Scholar
  152. 152.
    Kawaoka Y, Nestorowicz A, Alexander DJ, Webster RG. Molecular analyses of the hemagglutinin genes of H5 influenza viruses: origin of a virulent turkey strain. Virology 1987 May;158(1):218–27.PubMedCrossRefGoogle Scholar
  153. 153.
    Bosch FX, Von Hoyningen-Huene V, Scholtissek C, Rott R. The overall evolution of the H7 influenza virus haemagglutinins is different from the evolution of the proteolytic cleavage site. The Journal of General Virology. 1982 Jul;61 (Pt l):101–4.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  1. 1.Barclay Influenza GroupImperial College LondonLondonUK

Personalised recommendations